CENTER LABORATORIES, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 43.05 TWD | +0.23% |
|
-3.80% | -2.82% |
| Sales 2022 | 768M 23.64M | Sales 2023 | 1.39B 42.92M | Capitalization | 30.63B 943M |
|---|---|---|---|---|---|
| Net income 2022 | 102M 3.14M | Net income 2023 | -995M -30.63M | EV / Sales 2022 | 38.1 x |
| Net Debt 2022 | 1.12B 34.49M | Net Debt 2023 | 2.2B 67.65M | EV / Sales 2023 | 23.5 x |
| P/E ratio 2022 |
278
x | P/E ratio 2023 |
-29.5
x | Employees | - |
| Yield 2022 |
2.1% | Yield 2023 |
3.39% | Free-Float | 74.37% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +0.23% | ||
| 1 week | -3.80% | ||
| Current month | -0.46% | ||
| 1 month | +0.47% | ||
| 3 months | -4.76% | ||
| 6 months | -5.28% | ||
| Current year | -2.82% |
1 week
42.40
44.45
1 month
42.2545.30
Current year
42.0549.25
1 year
40.8061.77
3 years
38.5761.77
5 years
22.0567.47
10 years
22.0567.47
| Managers | Title | Age | Since |
|---|---|---|---|
Jui Pao Hsu
CEO | Chief Executive Officer | - | 98-08-02 |
An Ni Mao
DFI | Director of Finance/CFO | - | 22-12-07 |
Su Chi Wang
CHM | Chairman | - | 00-07-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Su Chi Wang
CHM | Chairman | - | 00-07-31 |
Chang-Hai Tsai
BRD | Director/Board Member | 74 | 22-05-19 |
Po Chih Chang
BRD | Director/Board Member | - | 10-06-13 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 117 M€ | -1.58% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 7 M€ | -0.01% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-17 | 43.05 | +0.23% | 465 228 |
| 24-04-17 | 42.95 | +1.06% | 794,328 |
| 24-04-16 | 42.5 | -1.62% | 1,562,539 |
| 24-04-15 | 43.2 | -1.37% | 1,139,439 |
| 24-04-12 | 43.8 | -1.02% | 1,068,834 |
End-of-day quote Taipei Exchange, April 17, 2024
More quotes
Center Laboratories, Inc. is a Taiwan-based company principally engaged in the production, marketing and distribution of infant nutrition products, as well as the research and development, processing, production, packaging, marketing and sales of dairy products. The Company's main products include dairy products and probiotic products. The Company is also involved in the manufacture, wholesale and retail of western medicines. The Company distributes its products in the domestic market and to overseas markets.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -2.82% | 907M | |
| +27.72% | 676B | |
| +23.58% | 554B | |
| -7.36% | 349B | |
| +14.57% | 318B | |
| +6.38% | 291B | |
| +2.96% | 210B | |
| -0.41% | 204B | |
| -10.02% | 194B | |
| -11.97% | 144B |
- Stock Market
- Equities
- 4123 Stock
